Tirzepatide compared to other GLP-1 medications for mental health If anxiety is a significant concern, understanding how tirzepatide compares to other medications in its class can help inform treatment decisions
Source: Bullets generated by AI with editorial review Americans are using GLP-1 weight-loss drugs at a record pace, with Gallup finding that use has nearly quadrupled since 2024, putting pressure on employers to find sustainable ways to cover the medications
And weight loss shakes dont have to be about restriction
How many people are diagnosed with aplastic anemia each year
Rybelsus (Semaglutide) Rybelsus made history with its FDA approval on September 20, 2019 as the first oral GLP 1 receptor agonist
Malheureusement, la tendance actuelle va compltement linverse, avec une augmentation constante de lembonpoint et de lobsit touchant les plus jeunes, les mettant trs haut risque de dvelopper une vritable pidmie de maladies cardiomtaboliques dans quelques annes (voir notre article ce sujet)